2-oxo-3-benzyl-benzoxazol-2-one derivatives and related compounds as Met kinase inhibitors for the treatment of tumors

Details for Australian Patent Application No. 2008258366 (hide)

Owner Merck Patent GmbH

Inventors Stieber, Frank; Blaukat, Andree; Dorsch, Dieter; Schadt, Oliver

Agent Davies Collison Cave

Pub. Number AU-A-2008258366

PCT Pub. Number WO2008/148449

Priority 10 2007 026 341.6 06.06.07 DE

Filing date 8 May 2008

Wipo publication date 11 December 2008

International Classifications

C07D 413/10 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/424 (2006.01) - condensed with heterocyclic ring systems, e.g. clavulanic acid

A61K 31/437 (2006.01)

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 35/00 (2006.01) Antineoplastic agents

C07D 498/06 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

28 January 2010 PCT application entered the National Phase

  PCT publication WO2008/148449 Priority application(s): WO2008/148449

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008258375-Terminal block and contact element for telecommunications and data systems

2008258365-Membrane with suction cups having the shape of an open hourglass moulded in flexible thermoplastic material onto a hydrophilic and/or breathable support